Draig Therapeutics
Draig Therapeutics develops neuropsychiatric medicines.
$65MSeries B
Role not disclosedActivity from announced rounds
Draig Therapeutics develops neuropsychiatric medicines.
Trains workforces in AI and tech skills through apprenticeships for enterprise employers
Provides end-to-end AI platform for autonomous driving licensed to automakers and mobility platforms
Develops inhaled therapies for severe respiratory diseases
Poolside develops AI models and tools for software development in enterprise environments.